Naproxen Sodium 11673-0764
Product NDC
11673-0764- Manufacturer
- Target Corporation
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- March 1, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA091353
Active Ingredients
| Ingredient | Strength |
|---|---|
| Naproxen Sodium | 220 mg/1 |
Drug Class
Anti-Inflammatory AgentsNon-Steroidal [CS]Cyclooxygenase Inhibitors [MoA]
Packaging Options(2)
50 TABLET in 1 BOTTLE (11673-764-05)
90 TABLET in 1 BOTTLE (11673-764-09)